08Mar
15Jan
From Startup to Publicly Traded Company: Story of Corbus Pharmaceuticals
The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels. Corbus Pharmaceuticals Wins Exit of the Year Award Corbus Pharmaceuticals is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. One of the great successes in the Boston Harbor Angels portfolio, Corbus was awarded Exit of the Year at the annual end-of-year general meeting in December 2017. Yuval Cohen, CEO of Corbus Pharmaceuticals and Mark Tepper, President &...
14Jan
Applying for Angel Funding- Part 1: The Angel’s Perspective
Boston Harbor Angels member Jeff Arnold will be speaking at Applying for Angel Funding-Part 1 on February 7 at Suffolk University. The event is sponsored by The Capital Network. Learn more >>
05Jan
Go Write the Ad: Tips from David Friend, CEO and Co-founder of Wasabi
The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels. Wasabi Wins IT Startup of the Year This past December, the Boston Harbor Angels hosted its annual end-of-year general meeting. During the meeting, Wasabi was honored as IT Startup of the Year. Wasabi is a new cloud storage company. After the awards, Mic Williams, President and Founder of Boston Harbor Angels, interviewed David Friend, CEO and co-founder of Wasabi. During the interview, Friend shared some history about his...
28Dec
Boston Harbor Angels Profile
Boston Harbor Angels (BHA) is one of the most prominent angel investing groups in the US with numerous successful exits. Read profile >>
15Dec
Boston Harbor Angels Awards Portfolio Companies at Annual Meeting
Boston Harbor Angels, one of the top three elite angels groups in the US, recognized three portfolio companies at its annual end-of-year general meeting. Exit of the Year Award: Corbus Pharmaceuticals on NASDAQ Biotech Startup of the Year Award: Astrocytes Pharmaceuticals Inc. IT Startup of the Year Award: Wasabi The meeting featured interviews with Yuval Cohen, CEO of Corbus Pharmaceuticals and Mark Tepper, President & Chief Scientific Officer of Corbus Pharmaceuticals; and David Friend, CEO and co-founder of Wasabi. The group also honored Mic Williams,...
23Nov
Investing. It’s a numbers game.
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. In episode three, Moukheiber and Powsner interview Mic Williams, founder of Boston Harbor Angels and angel investor extraordinaire, on his winning philosophy of investing — and a few stories, too. Tune in >>
01Oct
Applying for Angel Funding- Part 1: An Angel’s Perspective: Hub Angels, Launchpad, Golden Seeds & Boston Harbor Angels give their perspectives
Member David Kessler representing Boston Harbor Angels at this interactive session on Tuesday, October 3! Applying for Angel Funding- Part 1: An Angel’s Perspective. Read more >>
16Aug
What Are Investors Looking For?
The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels. Original post can be found here >> As fundraising is an area that entrepreneurs often have questions about, the Summer Venture Program invited three investors to share their side of the story. We were privileged to have Natalie Bartlett of General Catalyst/Rough Draft Ventures; Ziad Moukheiber, CEO of Boston Harbor Angels; and Jason Frishman, Founder of NetCapital provide their insights. The three panelists represented “Investors of All...
02Aug